⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11023144 | 0.74 | — | — | |
| SCHEMBL9336301 | 0.70 | — | — | |
| SCHEMBL3826889 | 0.70 | — | — | |
| SCHEMBL9021433 | 0.67 | — | — | |
| SCHEMBL9021721 | 0.67 | — | — | |
| SCHEMBL20663310 | 0.62 | — | — | |
| SCHEMBL3904360 | 0.60 | — | — | |
| SCHEMBL2169129 | 0.59 | — | — | |
| SCHEMBL6860057 | 0.59 | — | — | |
| SCHEMBL22042138 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120251927-A1 | HOLOGRAM-RECORDING MEDIUM | KABUSHIKI KAISHA TOSHIBA (JP) | 2012-10-04 | — | — | US | claimed |
| EP-0376218-B1 | Racemization free attachment of amino acids to solid phase | PERSEPTIVE BIOSYSTEMS INC (US) | 1999-02-24 | — | — | EP | claimed |
| US-5187270-A | Solid phase synthesis of peptides using the reaction product of an N-protected amino acid and a 2,4-dichlorophenyl (4-halo methylphenoxy)acetate; efficiency; purity; kinetics | MILLIPORE CORPORATION (US) | 1993-02-16 | — | — | US | claimed |
| EP-0376218-A2 | Racemization free attachment of amino acids to solid phase | PERSEPTIVE BIOSYSTEMS, INC. (US) | 1990-07-04 | — | — | EP | claimed |
| US-20240226309-A1 | HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND CETUXIMAB | Synthorx, Inc. (US) | 2024-07-11 | — | — | US | disclosed |
| EP-4395901-A1 | COMPOSITIONS AND METHODS FOR MODULATING KRAS EXPRESSION | Molecular Axiom, LLC (US) | 2024-07-10 | — | — | EP | disclosed |
| EP-4396349-A1 | COMPOSITIONS AND METHODS FOR MODULATING NLRP3 OR NLRP1 EXPRESSION | Molecular Axiom, LLC (US) | 2024-07-10 | — | — | EP | disclosed |
| US-20240218027-A1 | NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | THE SCRIPPS RESEARCH INSTITUTE | 2024-07-04 | — | — | US | disclosed |
| CN-112105627-B | Unnatural base pair compositions and methods of use | 斯克利普斯研究所 | 2024-07-02 | — | — | CN | disclosed |
| WO-2024137864-A1 | CANCER THERAPY WITH IL-2 CONJUGATES AND CHIMERIC ANTIGEN RECEPTOR THERAPIES | Synthorx, Inc. (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024137991-A2 | ENGINEERED GUIDE RNAS AND POLYNUCLEOTIDES | SHAPE THERAPEUTICS INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024136899-A1 | CANCER THERAPY WITH IL-2 CONJUGATES AND CHIMERIC ANTIGEN RECEPTOR THERAPIES | Synthorx, Inc. (US) | 2024-06-27 | — | — | WO | disclosed |
| US-5817603-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-10-06 | — | — | US | disclosed |
| US-5807897-A | MUSCULAR DISORDERS | ZENECA LIMITED (GB) | 1998-09-15 | — | — | US | disclosed |
| US-4897416-A | 5-OXIMINO-13B-CARBONYLTHIOMILBEMYCIN DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1990-01-30 | — | — | US | disclosed |
| EP-0279783-A1 | Insecticides and parasiticides | CIBA-GEIGY AG (CH) | 1988-08-24 | — | — | EP | disclosed |
| US-4374765-A | Mammalian collagenase inhibitors | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-02-22 | — | — | US | disclosed |
| US-4371466-A | Mammalian collagenase inhibitors | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-02-01 | — | — | US | disclosed |
| US-4371465-A | Mammalian collagenase inhibitors | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-02-01 | — | — | US | disclosed |
| US-4093609-A | Somatostatin synthesis | AMERICAN HOME PRODUCTS CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |